Coxsackievirus B3 Antibody
<strong>Coxsackievirus B3 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2016396_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Coxsackievirus B3, antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Carai P, González LF, Van Bruggen S, Spalart V, De Giorgio D, Geuens N, Martinod K, Jones EAV, Heymans S. Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis Cardiovasc Res. 2023 Jan 18;118(17):3331-3345._x000D_ 2: Kishimoto C, Kurokawa M, Ochiai H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis J Mol Cell Cardiol. 2002 Sep;34(9):1227-38._x000D_ 3: Förster W, Bialasiewicz AA, Busse H. Coxsackievirus B3-associated panuveitis Br J Ophthalmol. 1993 Mar;77(3):182-3._x000D_ 4: Jarasch-Althof N, Wiesener N, Schmidtke M, Wutzler P, Henke A. Antibody-dependent enhancement of coxsackievirus_B3 infection of primary CD19+ B lymphocytes Viral Immunol. 2010 Aug;23(4):369-76._x000D_ 5: Godney EK, Arizpe HM, Gaunti CJ. Characterization of the antibody response in vaccinated mice protected against Coxsackievirus_B3-induced myocarditis Viral Immunol. 1987-1988;1(4):305-14._x000D_ 6: Ettischer-Schmid N, Normann A, Sauter M, Kraft L, Kalbacher H, Kandolf R, Flehmig B, Klingel K. A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity Virchows Arch. 2016 Nov;469(5):553-562._x000D_ 7: Lindberg AM, Stålhandske PO, Pettersson U. Genome of coxsackievirus_B3 Virology. 1987 Jan;156(1):50-63._x000D_ 8: Massilamany C, Gangaplara A, Reddy J. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy Int J Cardiol. 2014 Dec 15;177(2):330-339._x000D_ 9: Girn J, Kavoosi M, Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain J Gen Virol. 2002 Feb;83(Pt 2):351-358._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/27250900">10: Kaga A, Katata Y, Suzuki A, Otani K, Watanabe H, Kitaoka S, Kumaki S. Perinatal Coxsackievirus B3 Infection with Transient Thrombocytopenia Tohoku J Exp Med. 2016 Jun;239(2):135-8. </a>_x000D_ _x000D_ <strong>Products Related to Coxsackievirus B3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
CAS Number
9007-83-4
Short Description
Catalog Number: B2016396 (500 ug)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog